Search results
-
Professor Kathryn Lilley
The research carried out in the Cambridge Centre for Proteomics centres around ...
-
Dr Laura Blackburn
... systems to support the effective translation of biomedical research into healthcare. We have a particular interest in circulating ... in terms of cancer management. In 2017 we carried out research and held a workshop on the implementation of the first ctDNA testing ...
-
Dr Lucy Faulkner
My research looks at epigenetic changes in circulating tumour DNA (ctDNA) for ...
-
Dr Liam Cassidy
Primary research focuses on understanding how the ageing process, and processes ...
-
Professor Laura Itzhaki
Our research focuses on a class of proteins known as tandem-repeat proteins such as ...
-
Dr Luca Pellegrini
... major contributing factor in human disease. The goal of our research is to understand structure and function of the macromolecular ...
-
Dr John Lizhe Zhuang
... risk stratification, and early intervention in cancer. My research primarily focuses on oesophageal adenocarcinoma (OAC) and its ... efforts. Using BO and OAC as a disease model, my research endeavours to address a fundamental question: how do early-stage ... to what extent can we decipher their risk of progression? My research explores both intrinsic and extrinsic factors that initiate BO and ...
-
Professor Margaret Ashcroft
Our research focuses on understanding the molecular mechanisms regulating the ...
-
Dr Mike Chapman
... targeted for therapeutic benefit. The initial focus of our research is the role of aberrant RNA processing in myeloma biology, based on ...
-
Dr Marc de la Roche
... epithelial stem cells leading to tumorigenesis. My primary research interests are to uncover regulatory nodes within oncogenic Wnt ... therapeutic entry points. At the heart of my research program are in the establishment of two tractable models of CRC to ...
-
Professor Brian Huntly
... of leukaemia stem cells and are examining self-renewal programmes downstream of leukaemia-associated oncogenes and a known ...
-
Dr Daniel Hodson
... to apoptosis. Rapidly changing, but tightly controlled, programmes of gene expression determine successive cell fate choices during the ...
-
Mrs Gill Kortum
... Manager for both the Paediatric Cancer and Neuro-oncology programmes in the CRUK Cambridge Centre. ...
-
Dr Hedley Carr
... across a range of drug discovery and clinical development programmes in a variety of cancer settings. ...
-
Dr Juliet Usher-Smith
... to help prevent cancer and inform stratified screening programmes. ...
-
Dr Kelly Fagan Robinson
... peoples' concerns about screening and other early detection programmes, which in turn has fostered development of insights into ...
-
Professor Ming-Qing Du
... We have been undertaking a series of research programmes to elucidate the pathology, immunophenotype, and molecular genetics ...
-
Mr Michael Simmons
... two interdisciplinary computational radiotherapy research programmes. ...
-
Dr Tim Mitchell
... FLT3 & TYK2 kinase cancer and autoimmune disease research programmes. SKIL® can also generate drug research programmes against other kinase targets. ...
-
Dr Steven Bell
I am an Epidemiologist based within the Precision Breast Cancer Institute , Department of Oncology at the University of Cambridge. At present my work utilises next-generation sequencing data alongside bioinformatic approaches to obtain insights...
-
Dr Ashwin Seshia
... biophysical tools to characterise biological systems at the molecular, cellular and multi-cellular scales. ...
-
Dr Alejandra Bruna
... a panel of breast cancer cell lines that represent the molecular heterogeneity present in primary tumors. In vitro and in vivo assays ... We are now focusing on trying to unravel the underlying molecular mechanisms of the dual effects of TGF-beta in BCSCs. ...
-
Dr Ahsan MEMON
... measure local forces, and re-localise or switch cellular and molecular behaviour. As one of its first applications, this holographic ...
-
Professor Alan Warren
Our long-term goal is to elucidate the molecular mechanisms of ribosome assembly in eukaryotic cells and to understand ...
-
Dr Annalisa Mupo
Acute myeloid leukemia (AML) is a molecularly diverse malignancy representing 15-20% of all childhood and around 35% of all adult leukemias. My work aims to study commonly occurring mutations in AML-NK (normal karyotype) using sophisticated mouse models.
-
Mr Alex Frankell
Interpretation of Genomic data to inform in vitro molecular analysis and identify important drivers of Oesophageal adenocarcinoma ...
-
Dr Anna Piskorz
I’m a molecular biologist focus on translational research in high grade serous ... (blood, plasma, ascites). I have a special interest in molecular characterisation of ascites samples from HGSOC patients. My research ... close collaboration with Addenbrook’s hospital and Cancer Molecular Diagnostic Laboratory. I’m engaged in several clinical trails ...
-
Dr Tony Jackson
Proteomic approaches to plasma-membrane assemblies: Membrane proteins cluster together selectively as spatially-restricted, functionally integrated complexes. This can play an important role in many biological processes, including signal transduction....
-
Professor Tony Green
... myeloproliferative neoplasms. The Green lab is studying the molecular and cellular mechanisms whereby aberrant JAK/STAT signalling subverts ...
-
Dr Arnaud Comment
... in the numerous metabolic reactions taking place in vivo. Molecular Imaging by MR imaging, a recent discipline combining molecular biology and in vivo imaging, aims at differentiating tissues based ...
-
Mr Arqum Anwar
Rotation Project: The project aims to investigate the cellular role(s) of a novel factor expected to be involved in DNA damage ...
-
Dr Catherine Lindon
... to cancer. We have recently described a 'ubiquitome' of cellular components modified by ubiquitin at the end of mitosis, seeding new ...
-
Dr Adrien Hallou
... with wet lab biology experiments to understand the role of cellular heterogeneity in cell fate decision, pattern formation and tissue ...
-
Dr Alex Cagan
... acquiring mutations. Some of these mutations may influence cellular phenotypes, such as growth, resulting in clonal expansions. Over time ...
-
Dr Bristi Basu
I co-lead the Cambridge Experimental Cancer Medicine Centre with Prof Duncan Jodrell and the CRUK Cambridge Centre Pancreatic Cancer Programme with Dr Giulia Biffi. Other roles include Capacity Building leadership team within the Cambridge NIHR...
-
Dr Claudia Ribeiro de Almeida
... against pathogens, while maintaining genome stability and cellular homeostasis. ...
-
Dr Adelyne Chan
Biology of Ras-induced senescence
-
Professor Adrian Liston
We are focussed on understanding the biology of regulatory T cells within the tissues. How they migrate there, what ...
-
Dr Adrian Kelly
Biology of MHC class I and class II antigen processing and presentation pathways.
-
Dr Alex Samoshkin
... cancer research (NICHD and NCI, NIH, USA) and neuroscience biology (UNC, Chapel Hill, USA). ...
-
Dr Athena Matakidou
... will allow in-vivo investigations of the underlying tumour biology and the discovery of new methodologies for the detection, management ...
-
Programme Partners
... Babraham Institute Research focuses on the methods of communication in cells and how genes ... and to develop new treatments. Specific cancer related programmes are related to haematological malignancies and colorectal cancer. ...
-
PhD Studentships in Cancer Research at the University of Cambridge
PhD Studentships in Cancer Research at the University of Cambridge The University of Cambridge has ... to contribute to our research by joining one of our PhD programmes set to commence in October 2018. In addition to the excellent ...
-
Non-clinical MRes student profile - Robert Hanson 2018 cohort
... Robert Hanson , who started his MRes research project in 2018 explains his research and why he applied to the CRUK ... to the CRUK Urological Malignancies and Early Detection programmes. I am currently based in the Massie lab, investigating ...
-
Centre members celebrate University promotions
... Promotions process for their important contributions to research and teaching at the University. Seven Centre members have been ... Murray (Paediatric Cancer and Urological Malignancies Programmes) Murray_lab_2018_croppedborder.jpg ...
-
A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma
... the stability of cell identity-defining transcriptional programmes in cancer. Research Programme : Fundamental Biology of Cancer ...
